insitro
insitro is a machine-learning-driven drug discovery and development company founded in 2018 by Daphne Koller and headquartered in South San Francisco, California. It combines large-scale in vitro cellular data generated in its own automated labs with human clinical and genetic data to build predictive models of biology, aiming to bring better drugs faster to the patients most likely to benefit. Its therapeutic focus spans metabolism, oncology, and neuroscience, and its interdisciplinary teams pair life scientists, data scientists, and engineers. insitro operates no public developer API; it maintains open-source research and infrastructure tooling (such as the redun workflow engine) on its GitHub organization. Backed by a16z, GV, and the SoftBank Vision Fund.
insitro is profiled on the APIs.io network. Tagged areas include Company, Drug Discovery, Machine Learning, Biotechnology, and Life Sciences.
Kin Score
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Build 2
SDKs, sample code, and the tooling you integrate with
Access & Security 4
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API